22nd Century Group has reduced the outstanding principle of its Senior Secured Credit Facility from approximately $22.1 million to approximately $14.0 million as part of an amendment and waiver process with its lenders. The reduction reflects a waiver and repayment of the $7.5 million minimum cash balance required under terms of the original debenture agreements, which was held in an escrow account. The Company also assigned an existing promissory note pertaining to the Company’s previous holdings in Panacea Life Science Holdings as additional consideration in the debt reduction transaction. In a non-monetary exchange, the assigned value of the promissory note was allocated as $600,000 to further principal reduction and $2.0 million to a reduction in the put price associated with the lenders outstanding warrants, which portion was subsequently cancelled. The remaining principal loan balance of $14.0 million and remaining $500,000 of the put price will be due at maturity in 2026 in accordance with the original terms of the debenture agreements. The Company was not required to pay any cash to the lenders in connection with this transaction. Subsequent to the debt reduction, the Company announced the consummation of a public offering with $5.25 million in gross proceeds, which will be used for general operating purposes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on XXII:
- 22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
- 22nd Century Group (XXII) Reduces Debt by $8.1 Million
- Largest borrow rate increases among liquid names
- 22nd Century Announces Pricing of $5.25 Million Public Offering
- 22nd Century prices 10M shares at 52.5c in public offering